back-links Clemastine Pregnancy and Breastfeeding Warnings Clemastine is also known as: 12 Hour Allergy Relief, Allerhist-1 , Contac 12 Hour Allergy, Dailyhist-1, Dayhist Allergy, Dayhist-1, Leader Allerhist, Tavist , Tavist Allergy , Tavist-1 Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings Breastfeeding Warnings User Reviews Drug Images Support Group Q & A Pricing & Coupons Clemastine Pregnancy Warnings Among Michigan Medicaid recipients, 1617 exposures to clemastine were reported during the first trimester. (F. Rosa, personal communication, FDA, 1994) Birth defects were observed in 71 infants (68 expected) and included 13 cardiovascular defects, 3 oral clefts, 3 spina bifida, 4 polydactyly, 4 hypospadias, and 5 limb reductions. No evidence was found to suggest a relationship to large categories of malformations, except possibly limb reductions. A review of prenatal drug use in 3026 women with premature infants demonstrated an increased risk of retrolental fibroplasia with antihistamine use during the last two weeks of pregnancy. The dosage used or the particular antihistamine was not specified. The incidence of retrolental fibroplasia in premature infants exposed in utero to antihistamine during this time was 21% compared to 11% in premature infants not exposed. Clemastine has been assigned to pregnancy category B by the FDA. There are no controlled data in human pregnancy. Clemastine is only recommended for use during pregnancy when benefit outweighs risk. See references Clemastine Breastfeeding Warnings Clemastine is excreted into breast milk. One breast-fed infant developed drowsiness, irritability, refusal to feed, neck stiffness, and a high-pitched cry 12 hours after her mother began clemastine, 1 mg twice daily. The mother was also receiving carbamazepine and phenytoin. The infant returned to normal after clemastine was discontinued. Twenty hours after a dose of clemastine, the mother's serum and breast milk concentrations were 20 mcg/mL and 5 to 10 mcg/mL, respectively. The American Academy of Pediatrics recommends that clemastine be used with caution during breast-feeding. The manufacturer recommends that due to the potential adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. See references References for pregnancy information "Product Information. Tavist (clemastine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ. Zierler S, Purohit D "Prenatal antihistamine exposure and retrolental fibroplasia." Am J Epidemiol 123 (1986): 192-6 References for breastfeeding information "Product Information. Tavist (clemastine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ. Kok TH, Taitz LS, Bennett MJ, Holt DW "Drowsiness due to clemastine transmitted in breast milk ." Lancet 1 (1982): 914-5 Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50 Paton DM, Webster DR "Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines)." Clin Pharmacokinet 10 (1985): 477-97 Print this page See Also... Clemastine use while Breastfeeding (in more detail) clemastine Consumer Information Pregnancy Support Group FDA Pregnancy Categories Medicine use during Pregnancy Medicine use while Breastfeeding Safe Medications during Breastfeeding Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist. Drug Status Rx OTC Availability Rx and/or OTC B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Clemastine Rating 2 User Reviews 8.0 /10 2 User Reviews 8.0 Rate it! Drug Class Antihistamines Related Questions & Answers Where can I get clemastine 1.34 mg as my local Drug store cannot get this med? Read more questions waiting for
the plain Clemastine Pregnancy and Breastfeeding Warnings deliberating
EmoticonEmoticon